先天性膈疝新生儿静脉-静脉体外膜氧合期间溶血的前瞻性观察研究
该前瞻性观察研究纳入62例接受静脉-静脉体外膜氧合(ECMO)治疗的先天性膈疝(CDH)新生儿,每日监测血浆游离血红蛋白。14例(22.6%)发生溶血,溶血组死亡率为100%,非溶血组为31.1%(P < .001);多变量分析显示溶血和超体循环肺动脉高压是死亡的独立相关因素。
要点
- CDH新生儿V-V ECMO期间溶血发生率为22.6%,与死亡率独立相关。
- 溶血组死亡率100%,非溶血组31.1%(P < .001)。
- 使用8 Fr插管者溶血发生率显著高于13 Fr插管者(43% vs 17%,P = .039)。
核心结论
- CDH新生儿接受V-V ECMO期间发生溶血与死亡率独立相关,溶血是死亡的独立危险因素。
研究设计与样本
- 前瞻性观察研究,纳入62例需V-V ECMO治疗的CDH新生儿,使用Medos Deltastream循环、DP3泵、hilite 800 LT氧合器系统和¼英寸管路。
- ECMO期间每日一次采用分光光度法测定血浆游离血红蛋白(PFH),根据是否发生溶血将患者分为两组。
主要发现
- 溶血定义为ECMO期间至少连续2天PFH ≥ 50 mg/dL,14例(22.6%)发生溶血。
- 溶血组死亡率为100%,非溶血组死亡率为31.1%(P < .001)。
- 溶血严重程度:21.4%为中度(最高PFH 50-100 mg/dL),78.6%为重度(最高PFH >100 mg/dL)。
- 多变量分析显示,溶血(风险比6.8;95%CI 1.86-24.86)和超体循环肺动脉高压(风险比3.07;95%CI 1.01-9.32)与死亡率独立相关。
- 使用8 Fr插管者溶血发生率显著高于13 Fr插管者(43% vs 17%;P = .039)。
关键数值与推荐
- 溶血定义:ECMO期间至少连续2天PFH ≥ 50 mg/dL。
- 溶血分级:中度最高PFH 50-100 mg/dL,重度最高PFH >100 mg/dL。
- 预测溶血的相对ECMO流量截断值:8 Fr插管患者为115 ml/kg/分钟(AUC 0.786,P = .042),13 Fr插管患者为100 ml/kg/分钟(AUC 0.840,P < .001)。
临床怎么用
- 对CDH新生儿V-V ECMO期间应每日监测PFH以及时发现溶血。
- 关注插管尺寸对溶血风险的影响,8 Fr插管者溶血风险更高。
- 溶血和超体循环肺动脉高压可协助 identifying 死亡高危患儿。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the incidence of hemolysis and its association with outcome in neonates with congenital diaphragmatic hernia (CDH) requiring venovenous extracorporeal membrane oxygenation (ECMO) treatment using a Medos Deltastream circuit with a DP3 pump, a hilite 800 LT oxygenator system, and a ¼' tubing. STUDY DESIGN: Plasma free hemoglobin (PFH) was prospectively measured once daily during ECMO using spectrophotometric testing. Patients (n = 62) were allocated into two groups according to presence or absence of hemolysis. Hemolysis was defined as PFH ≥ 50 mg/dL on at least 2 consecutive days during ECMO treatment. Hemolysis was classified as either moderate with a maximum PFH of 50-100 mg/dL or severe with a maximum PFH >100 mg/dL. RESULTS: Hemolysis was detected in 14 patients (22.6%). Mortality was 100% in neonates with hemolysis compared with 31.1% in neonates without hemolysis (P < .001). In 21.4% hemolysis was moderate and in 78.6% severe. Using multivariable analysis, hemolysis (hazard ratio: 6.8; 95%CI: 1.86-24.86) and suprasystemic pulmonary hypertension (PH) (hazard ratio: 3.07; 95%CI: 1.01-9.32) were independently associated with mortality. Hemolysis occurred significantly more often using 8 French (Fr) cannulae than 13 Fr cannulae (43% vs 17%; P = .039). Cutoff for relative ECMO flow to predict hemolysis were 115 ml/kg/ minute for patients with 8 Fr cannulae (Area under the curve [AUC] 0.786, P = .042) and 100 ml/kg/ minute for patients with 13 Fr cannulae (AUC 0.840, P < .001). CONCLUSIONS: Hemolysis in CDH neonates receiving venovenous ECMO is independently associated with mortality.
引用
- Lemloh L, Bo B, Ploeger H, et al. Hemolysis during Venovenous Extracorporeal Membrane Oxygenation in Neonates with Congenital Diaphragmatic Hernia: A Prospective Observational Study. J Pediatr. 2023. PMID: 37659588. doi:10.1016/j.jpeds.2023.113713
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。